Explore / Peer-reviewed article
Peer-reviewed article

Analgesic efficacy of intravenous lidocaine vs ketamine in refractory chronic pain: a retrospective analytic study with 3-month follow-up.

Kositanurit K, Chalermkitpanit P, Limtrakool N, Assavanop SiD

Pain medicine (Malden, Mass.)Jul 1, 20260 citationsDOI: 10.1093/pm/pnag022

Abstract

<h4>Background</h4>Refractory chronic pain conditions remain challenging to manage, and intravenous infusions of ketamine, lidocaine, or their combination have emerged as potential therapeutic options.<h4>Objective</h4>To evaluate the analgesic effectiveness and safety of intravenous lidocaine, ketamine, and their combination in patients with refractory chronic pain.<h4>Methods</h4>We conducted a retrospective analytic study of patients treated between January 2020 and November 2024 at an outpatient pain clinic. Eligible patients had persistent severe pain (numerical rating scale [NRS] > 6/10) despite ≥3 months of multimodal pain management and received intravenous lidocaine, ketamine, or combination infusions. The primary outcome was immediate pain reduction post-infusion. Secondary outcomes included pain relief at 1 and 3 months, quality of life (QoL) assessed by EQ-5D-5L, and associations between clinical characteristics and treatment response.<h4>Results</h4>A total of 120 patients were included. All 3 groups demonstrated significant reductions in NRS scores from baseline after the first infusion, with mean differences of 3.09 (95% CI 2.56-3.62) for lidocaine, 2.30 (95% CI 1.48-3.13) for ketamine, and 3.95 (95% CI 3.33-4.57) for combination therapy. Analgesic effects persisted at 1- and 3-month follow-up. Mild, self-limiting adverse effects occurred in 7.5% of patients. The combination group showed superior pain reduction at selected time points and greater improvements in QoL at 3 months.<h4>Conclusions</h4>Intravenous lidocaine, ketamine, and combination infusions provide immediate and sustained pain relief in refractory chronic pain. Combination therapy may offer additional benefit beyond monotherapy, supporting its consideration in clinical practice.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetaminePain

Keywords

Ketamine InfusionLidocaine InfusionRefractory Chronic Pain

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.